Genelancet Biosciences

Developer of gene editing technology

placeBurlingame, California, United States calendar_todayFounded 2019 groups3 employees language genelancetbio.com

Social engagement

Social engagement: 586 social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

15 Apr 2026
Milestone
regulatory
13 Mar 2026
Product launch
DuoSTAR platform
18 Aug 2025
Event
ACS Fall 2025 Meeting
Coming soon